Patients were randomly assigned to receive either 6 mmol KNO3 first (n = 41) or 6 mmol potassium chloride (KCl) first (n = 43) three times daily for 6 weeks, with a 1-week washout period in between.

The US Food and Drug Administration has placed its most serious warning – a so-called black-box warning – on a drug used to relieve menopausal hot flashes. The FDA says women who are taking ...

Potassium chloride, according to The George Institute for Global ... Furthermore, it can increase risk for people taking certain medications. “People taking potassium-sparing diuretics such as ...

A drug used to treat HIV that has also shown promise in preventing infections is not a cure for those already infected, as claimed in social media posts. Apart from rare and dangerous stem cell ...